Clinical trials
Heart Defects, Congenital trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 3 |
| Instituto de Cardiologia do Rio Grande do Sul | 3 |
| Great Ormond Street Hospital for Children NHS Foundation Trust | 2 |
| Istanbul University - Cerrahpasa | 2 |
| Umeå University | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Altoosi University College | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Augusta University | 1 |
| Azienda Ospedaliera di Padova | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Defects, Congenital | 58 |
| Aortic Coarctation | 2 |
| Arrhythmias, Cardiac | 2 |
| Cystic Fibrosis | 2 |
| Death, Sudden, Cardiac | 2 |
| Heart Valve Diseases | 2 |
| Hypertension, Pulmonary | 2 |
| Pulmonary Arterial Hypertension | 2 |
| Tetralogy of Fallot | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.